Nuvalent, Inc.
NUVLDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001861560
Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Nuvalent, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 172 | 2 | 193 | +23 |
| Shares | 65.6M | 3.02M | 70.1M | +7.57M (+12.1%) |
| Value | $4.98B | $229.4M | $7.17B | +$2.43B (+51.1%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (47)
Institutions that held Nuvalent, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (24)
Institutions that held Nuvalent, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Bank of Montreal | 77,755 | $6.29M |
| Atom Investors LP | 59,277 | $4.50M |
| Renaissance Capital LLC | 28,481 | $2.16M |
| ExodusPoint Capital Management, LP | 17,543 | $1.33M |
| Tudor Investment Corp Et Al | 12,788 | $970.1K |
| Cinctive Capital Management LP | 12,529 | $950.5K |
| Gsa Capital Partners LLP | 12,132 | $920.0K |
| Bank of Hawaii | 6,995 | $530.6K |
| Trexquant Investment LP | 6,110 | $463.5K |
| Schonfeld Strategic Advisors LLC | 5,700 | $432.4K |
| Axq Capital, LP | 3,405 | $258.3K |
| Aigen Investment Management, LP | 3,266 | $247.8K |
| Algert Global LLC | 2,954 | $224.1K |
| HSBC Holdings PLC | 2,701 | $203.1K |
| Mount Yale Investment Advisors, LLC | 2,655 | $201.4K |
| EntryPoint Capital, LLC | 2,294 | $174.0K |
| Allspring Global Investments Holdings, LLC | 2,212 | $167.8K |
| Quest Partners LLC | 574 | $43.5K |
| Pacer Advisors, Inc. | 368 | $27.9K |
| Harvest Fund Management Co., Ltd | 306 | $23.0K |
| nVerses Capital, LLC | 300 | $22.8K |
| Oliver Lagore Vanvalin Investment Group | 76 | $5.76K |
| Continuum Advisory, LLC | 28 | $2.12K |
| Lynx Investment Advisory | 15 | $1.14K |
Not filed for Q3 2024 yet (2)
Institutions that held Nuvalent, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,023,626 | $229.4M |
| Institutional & Family Asset Management, LLC | 8 | $607 |